COR
Cencora, Inc.
NYSE · USHealthcareMedical - Distribution
$303.99-1.27%
Price as of Jul 20, 2026
COR profitability
Cencora, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 3.5%
- EBITDA margin
- 1.5%
- EBIT margin
- 1.3%
- Net margin
- 0.8%
- Free cash flow margin
- 0.5%
Returns
- Return on equity
- 75.0%
- Return on assets
- 3.1%
- Return on invested capital
- 26.6%
- Asset turnover
- 4.11x
Cash efficiency
- Cash from operations
- $2.3B
- Cash per share
- $11
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.